Will semaglutide (or an alternative) cost less than $100/month (inflation-adjusted) without insurance in 2040?

High probability that semaglutide will cost under $100/month in 2040 without insurance.

The market indicates a strong belief (94.16%) that semaglutide or an alternative will be priced below $100 per month in 2040 without insurance. The Pulse AI also supports this view, albeit with a slightly lower probability of 88.16%. The NO side appears undervalued by 6 points, suggesting potential market mispricing.

• 1 Current sentiment strongly favors a YES outcome.
• 2 Market probability shows a significant consensus on affordability.
• 3 The NO side's undervaluation indicates possible market inefficiencies.
• 4 Pulse AI aligns closely with market sentiment but is slightly more conservative.
• 5 Time to expiry allows for potential shifts in market dynamics.